Overview

A Study of the Safety of INCB054707 in Participants With Hidradenitis Suppurativa

Status:
Completed
Trial end date:
2019-04-22
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the safety of INCB054707 in men and women with moderate to severe hidradenitis suppurativa (HS).
Phase:
Phase 2
Details
Lead Sponsor:
Incyte Corporation